Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy
- PMID: 17879933
- DOI: 10.1086/521938
Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy
Comment on
-
Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis.Clin Infect Dis. 2007 Mar 15;44(6):788-93. doi: 10.1086/511643. Epub 2007 Feb 2. Clin Infect Dis. 2007. PMID: 17304449 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
